MARKET

BIOC

BIOC

Biocept
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6651
-0.0049
-0.73%
Opening 12:51 11/14 EST
OPEN
0.7323
PREV CLOSE
0.6700
HIGH
0.7400
LOW
0.6600
VOLUME
805.57K
TURNOVER
--
52 WEEK HIGH
3.720
52 WEEK LOW
0.6270
MARKET CAP
15.31M
P/E (TTM)
-0.1376
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIOC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BIOC News

  • Biocept, Inc. (BIOC) CEO Michael Nall on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.14h ago
  • Biocept EPS beats by $0.02, beats on revenue
  • seekingalpha.15h ago
  • Biocept Q3 EPS $(0.25) Beats $(0.27) Estimate, Sales $1.53M Beat $1.45M Estimate
  • Benzinga.20h ago
  • Biocept Reports Third Quarter 2019 Financial Results
  • PR Newswire.20h ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.06%
Healthcare Equipment & Supplies
+0.10%

Hot Stocks

Name
Price
%Change

About BIOC

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.
More

Webull offers Biocept Inc (BIOC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.